538 the Vascular Inflammation in Psoriasis (VIP) Trial: A Secondary Analysis of Patient Reported Outcomes for Patients Treated With Adalimumab, Phototherapy, or Placebo
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.614
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV